Last €44.49 EUR
Change Today -0.247 / -0.55%
Volume 20.0
AG8 On Other Exchanges
Symbol
Exchange
Frankfurt
As of 5:42 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States

Phone: 408-345-8886

Fax: 408-345-8474

get primary cancer diagnostics through Hematoxylin and Eosin staining, as well as Special Stains for additional insights and detection of potentially carcinogenic tissue. In 2013, the company launched its new combined IHC/ in situ hybridization platform, Dako Omnis. The Dako Omnis and Autostainer based IHC solution and instant quality fluorescence in situ hybridization technologies provides advanced tumor typing through investigation of protein and gene expression. These products also include companion diagnostic tests that are used to help identify patients most likely to benefit from a specific targeted therapy. Specific Proteins and Flow Reagents: The company’s reagent OEM business is a provider of clinical diagnostic products within the areas of specific proteins for turbidimetry and reagents for flow cytometry. These are sold OEM as customized reagent solutions supplied to top in vitro diagnostics companies or through retail partners. Target Enrichment: The company provides a target enrichment portfolio composed of two main platforms, SureSelect and HaloPlex, both enabling customers to select specific target regions of the genome for sequencing. Customers can customize the company’s products for their regions of interest using the SureDesign software, or they can choose from a range of catalog products, including gene panels for specific applications and Exome designs, which allow analysis of the entire coding sequences of the genome. After preparing samples with SureSelect and HaloPlex, products can be sequenced in the main next generation sequencing platforms available in the market. The company’s products are used for mutation detection and genotyping. Cytogenetic Research Solutions and Microarrays: The company provides microarrays for comparative genomic hybridization, mostly used by customers in cytogenetic laboratories. The arrays allow customers to detect genome-wide copy number alterations, with high levels of resolution (from entire chromosomal copy number changes to specific microdeletions or duplications). The arrays are offered in many formats allowing the customers to choose from different levels of resolution and number of samples per arrays. Arrays can also be customized using the SureDesign software. In addition to the microarrays, the company’s solution includes reagents for sample processing, hardware for reading the microarrays, and software to help users view the data in a meaningful way. In addition to the comparative genomic hybridization portfolio, the cytogenetics solution consists of a line of oligonucleotide probes for fluorescent in situ hybridization (FISH) called SureFISH. Cytogenetic labs can use SureFISH probes to detect specific translocations or copy number changes in samples. Additionally, the company provides a range of microarrays to the research market for different types of applications: gene expression, microRNA, methylation, splice variants, and chromatin immunoprecipitation applications. The company s solution includes reagents for sample preparation and microarray processing; hardware for sample QC and high-throughput microarray scanning; microarrays on industry-standard 1 inche × 3 inchdes glass slides for key applications; custom microarray design services; and GeneSpring software products for data analysis. Polymerase Chain Reaction (PCR) and Quantitative PCR (qPCR) Instrumentation and Molecular Biology Reagents: PCR is a standard laboratory method used to amplify the amount of genetic material of a given sample to enable further interrogation. qPCR or real time PCR is also a standard method used in genomic research facilities to measure the amount of a specific nucleic acid sequence within a sample. The company offers a portfolio of PCR and qPCR instruments, as well as specialty enzymes for amplifying difficult sample types. In addition to PCR and qPCR enzymes, the company offers a range of molecular biology reagents, including tools for cloning and mutagenesis applications. Life Sciences and Diagnostics Customers The company had approximately 46,000 customers for its life sciences and diagnostics business in 2013. A significant number of the company’s l

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG8:GR €44.49 EUR -0.247

AG8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Analog Devices Inc $49.61 USD +0.41
Applied Materials Inc $22.35 USD -0.02
Becton Dickinson and Co $114.50 USD +0.21
KLA-Tencor Corp $79.13 USD +0.85
NVIDIA Corp $19.07 USD -0.065
View Industry Companies
 

Industry Analysis

AG8

Industry Average

Valuation AG8 Industry Range
Price/Earnings 28.2x
Price/Sales 2.8x
Price/Book 3.4x
Price/Cash Flow 27.9x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILENT TECHNOLOGIES INC, please visit www.home.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.